Exatecan-Loaded HSA Nanoparticles for Sustained Release and Enhanced Cancer Treatment

Vazhayil Hari Krishnaprasad, Vijayashree Nayak, Ranjan Dey · 2026

Read Exatecan-Loaded HSA Nanoparticles for Sustained Release and Enhanced Cancer Treatment by Vazhayil Hari Krishnaprasad, Vijayashree Nayak, Ranjan Dey (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613872.txt.

Description

A potent cancer drug was shelved because it harmed patients at useful doses and left the blood too fast. Vazhayil Hari Krishnaprasad and co-authors wrapped that drug in protein nanoparticles in this 2026 study. The drug, exatecan, blocks an enzyme cancer cells need to copy DNA. It comes from a natural plant compound family.

The wrapper is human serum albumin, the blood's main carrier protein. The particles came out even in size, at about 147 nanometers, with a mild negative charge. Imaging confirmed the drug spread evenly through the protein. In lab fluid, the particles released the drug slowly over nine days, faster in acid like that around tumors. Docking tests showed the drug binds the protein stably. Cancer cell tests showed strong killing.

Catalog record

CREATORVazhayil Hari Krishnaprasad, Vijayashree Nayak, Ranjan Dey
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13613872

Browse the full library · About the Tower of Babel